Correction–Vaccines for Children (VFC) RSV Recommendation
This message is being sent to Vaccines for Children (VFC) providers, local health officers, Tribal health directors, and Immunization Program staff.
The previous message listed the incorrect timeframe for administering Abrysvo to pregnant people. Abrysvo should be administered to pregnant people from September through January.
RSV immunization ordering
RSV monoclonal antibodies
Beyfortus and Enflonsia, the RSV monoclonal antibodies, should be administered from October through March.
Similar to last year, Beyfortus is available in 50 mg or 100 mg presentations, in five dose packages. Ordering opened on August 4, to ensure providers have sufficient stock to start vaccination on October 1.
Enflonsia is available in single dose syringes, and will be available to order starting October 1, 2025, and will ship starting October 3, 2025.
RSV vaccine
Abrysvo, the RSV vaccine, should be should be administered to pregnant people from from September through January. Abrysvo is available to order through WIR for those that serve an eligible population.
Per the VFC requirements, it is an expectation that all providers that serve the eligible population will have RSV immunizations available throughout the RSV season.
For more information see the DHS flyer Respiratory Syncytial Virus
(RSV) Protection for Infants.
|
